|
From Jeremy Holmes, chief executive and registrar, RPSGB Sir, I would like to respond to Sandra Gidley's comments (C+D, p14, July 12) on leadership and visibility in response to the pharmacy in England white paper. I hope she is pleased... From Donald Davison FRPharmS, Manchester Sir,
May I please correct a statement attributed to me during my telephone off-the-cuff with your reporter (C+D, p5, July 5)? In 1948 we pharmacists in Sunderland had no concern whatsoever about GP dispensing... From Mark James, group managing director, AAH Pharmaceuticals Sir,
The recent poll conducted by C+D concerning the relationship between pharmacists and GPs highlighted interesting results that are a cause for both optimism and concern From Sue Oakley MRPharmS, Dorset Sir,
As a pharmacist with experience of working within PCTs, I am concerned about the way in which some pharmacies are carrying out MURs... Where is the job satisfaction? Sir,
I agree with everything written in the article entitled 'Down and out: pharmacists consider quitting under stress' (C+D, June 21, p4). I would quit today if I could find another job. .. From Georgina Craig, Commissioning Policy Lead, CCA Sir,
I was delighted to read in C+D’s story on polyclinics (June 21, p8) that the Department of Health “makes no apology for asking the NHS to invest in new GP services that will improve access and choice” – neither should it. However... I have been following your articles on category M with interest and was dismayed to read the response from the Association of Independent Pharmacy Groups... From Terry Hannawin, chief executive, Pharmaceutical Contractors Committee Sir,
The Pharmaceutical Contractors Committee has grave concerns about the Department's proposal for the central tendering of generic medicines in primary care. From Antony Marshall MRPharmS, Stoke-on-Trent Sir,
I work for a large multiple as a branch pharmacist and have to comment about your article on MURs... From Steve Churton, president, RPSGB Sir,
Xrayser raised some interesting issues in his column The best of British to you Mr Churton (C+D, 14 June). The fact is... from Andrew Gush, treasurer, RPSGB Sir,
As treasurer of the Society it is important that I put into context the comments made by the past president, Hemant Patel, in C+D recently claiming that the new professional body would need 30 per cent support to succeed... From Steve Churton, president, Royal Pharmaceutical Society Sir,
I read with interest the comments made by Hemant Patel in his interview with C+D last week (June 7, p12).As the Royal Pharmaceutical Society's new president, I am acutely aware of the challenge we face in preparing the profession for the future From Mark Griffiths, chairman, Cambrian Alliance Sir,
For the last three years, pharmacists have been examining their remuneration with increasing concern. Category M cuts and changes to the PPRS have come on top of the changed contract to hit pharmacy balance sheets and have created a very unstable financial regime... From Jean-Pierre Moser, Head of Corporate Communications, RPSGB Sir, Xrayser’s view on the Society’s Pharmacy Rx Factor initiative published last week (31 May) made for amusing reading. However there is a serious side to the initiative which it is important to highlight to C+D readers... Control of entry: does it kill competition? Sir,
It seems that all independents care deeply about the future of independent community pharmacy, that is, until they come to sell up and then it's every man for himself. From Ewan Black MRPharmS, manager and director, Greenhead Pharmacy, Dumbarton Sir,
I have been following with interest the debate emanating from C+D's Salary Survey. Its findings came as little surprise to me. Anecdotally, morale amongst community pharmacists is generally low. But why is this? |